Daniel Prieto-Alhambra researcher
Prieto-Alhambra, Daniel
VIAF ID: 362162664388855001393 (Personal)
Permalink: http://viaf.org/viaf/362162664388855001393
Preferred Forms
- 100 0 _ ‡a Daniel Prieto-Alhambra ‡c researcher
- 100 1 _ ‡a Prieto-Alhambra, Daniel
- 100 1 _ ‡a Prieto-Alhambra, Daniel
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom | |
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis | |
Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database | |
Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study | |
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study | |
The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data | |
Do we need to fine-tune the Spanish version of the FRAX predictive tool? | |
Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England | |
Drug utilization in patients with OA: a population-based study. | |
Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study | |
The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement surgery | |
The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study | |
Erratum to: Assessing risk of osteoporotic fractures in primary care: development and validation of the FRA-HS algorithm. | |
Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data | |
Excess cases of influenza suggest an earlier start to the coronavirus epidemic in Spain than official figures tell us: an analysis of primary care electronic medical records from over 6 million people from Catalonia | |
Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study | |
Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA. | |
Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index. | |
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial | |
Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose | |
Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study | |
High-dose oral vitamin D supplementation and risk of falls in older women | |
HIV infection, bone metabolism, and fractures. | |
The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study | |
The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study. | |
The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study. | |
Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance | |
The impact of the enhanced recovery pathway and other factors on outcomes and costs following hip and knee replacement: routine data study | |
Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. | |
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates | |
Increased hip fracture and mortality in chronic kidney disease individuals: the importance of competing risks. | |
Influence of pre-existing multimorbidity on receiving a hip arthroplasty: cohort study of 28 025 elderly subjects from UK primary care | |
Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis. | |
International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates | |
Lower limb arthroplasty: can we produce a tool to predict outcome and failure, and is it cost-effective? An epidemiological study | |
Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England: retrospective cohort analysis of hospital episode statistics | |
Opioid use in knee or hip osteoarthritis: a region-wide population-based cohort study | |
Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort | |
Osteoarthritis, 2014: | |
Patients With Atypical Femur Fractures Have the Same Mortality as the Background Population--Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications | |
Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study. | |
Preschool Obesity Is Associated With an Increased Risk of Childhood Fracture: A Longitudinal Cohort Study of 466,997 Children and Up to 11 Years of Follow-up in Catalonia, Spain | |
Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. | |
Prevalence of vertebral fracture and densitometric osteoporosis in Spanish adult men: The Camargo Cohort Study. | |
Primary hip replacement prostheses and their evidence base: systematic review of literature. | |
Real-Life and RCT Participants: Alendronate Users Versus FITs' Trial Eligibility Criterion | |
Relationship between mortality and BMI after fracture: a population-based study of men and women aged ≥40 years. | |
Reply | |
Risk levels for suffering a traffic injury in primary health care. The LESIONAT project | |
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study | |
Risks and Benefits of Bisphosphonate Therapies | |
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis | |
Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study | |
Secular trends of use of anti-osteoporotic treatments in Spain: A population-based cohort study including over 1.5million people and more than 12years of follow-up. | |
Self-reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS. | |
Serum Lipid Levels and Risk Of Hand Osteoarthritis: The Chingford Prospective Cohort Study | |
Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance | |
Smoking and Alcohol Intake but Not Muscle Strength in Young Men Increase Fracture Risk at Middle Age: A Cohort Study Linked to the Swedish National Patient Registry | |
Socioeconomic status and its association with the risk of developing hip fractures: a region-wide ecological study. | |
Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial | |
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users. | |
Surrogate markers of long-term outcome in primary total hip arthroplasty: A systematic review | |
Treatment of first-time traumatic anterior shoulder dislocation: the UK TASH-D cohort study | |
Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study | |
Validation of hip osteoarthritis diagnosis recording in the UK Clinical Practice Research Datalink | |
Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA study | |
Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer | |
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study. | |
প্রত্যুত্তর |